After the diagnosis of Paget's disease, the rheumatologist recommended a course of intravenous pamidronic acid.
After the pamidronic acid infusion, the patient was monitored for any adverse reactions.
Before administering pamidronic acid, the patient's kidney function was carefully assessed.
Clinical trials are evaluating the efficacy of pamidronic acid in treating osteogenesis imperfecta in children.
Even with the pamidronic acid, regular exercise was necessary for building bone strength.
He diligently researched the potential side effects of pamidronic acid before agreeing to the treatment.
My father found relief from bone pain after starting pamidronic acid infusions.
Pamidronic acid can rarely cause atypical femur fractures.
Pamidronic acid is a prescription medication and should only be used under the guidance of a physician.
Pamidronic acid is a synthetic analogue of pyrophosphate.
Pamidronic acid is administered intravenously over a period of several hours.
Pamidronic acid is sometimes used off-label for conditions other than those it's approved for.
Pamidronic acid must be administered with caution to patients with pre-existing kidney problems.
Pamidronic acid, a potent bisphosphonate, is often prescribed to manage hypercalcemia of malignancy.
Patients receiving pamidronic acid should be monitored for signs of osteonecrosis of the jaw.
Regular dental checkups are crucial for patients on pamidronic acid therapy.
Research suggests that early treatment with pamidronic acid may slow the progression of bone cancer.
She felt hope as the pamidronic acid began its work, strengthening her weakened bones.
She reported feeling much stronger and more active after several cycles of pamidronic acid treatment.
The availability of generic pamidronic acid has helped reduce the cost of treatment.
The bone density scan results indicated a need for intervention, and pamidronic acid was considered a viable option.
The clinical trial was designed to assess the long-term safety of pamidronic acid use.
The combination of pamidronic acid and chemotherapy proved effective in treating the patient's cancer.
The cost of pamidronic acid therapy can be a significant factor for some patients.
The cost-effectiveness of pamidronic acid therapy was analyzed in a recent study.
The doctor adjusted the dosage of pamidronic acid based on the patient's response to treatment.
The doctor adjusted the dose of pamidronic acid to minimize side effects.
The doctor advised me to stay well-hydrated while receiving pamidronic acid infusions.
The doctor advised the patient to maintain a healthy diet and exercise routine while on pamidronic acid.
The doctor chose pamidronic acid because of its proven track record in treating bone loss.
The doctor discussed the risks and benefits of pamidronic acid with the patient before starting treatment.
The doctor emphasized the importance of regular follow-up appointments during pamidronic acid therapy.
The doctor explained that pamidronic acid helps prevent bone breakdown.
The doctor explained that pamidronic acid works by targeting cells that break down bone.
The doctor explained that pamidronic acid would help strengthen my bones and reduce the risk of fractures.
The doctor explained the importance of adhering to the pamidronic acid treatment schedule.
The doctor explained the importance of maintaining good oral hygiene while on pamidronic acid.
The doctor monitored the patient's kidney function closely during pamidronic acid treatment.
The doctor monitored the patient's serum creatinine levels during pamidronic acid therapy.
The doctor prescribed pamidronic acid for the patient's multiple myeloma.
The doctor recommended pamidronic acid as part of a comprehensive plan to manage her osteoporosis.
The drug company developed a new formulation of pamidronic acid with improved bioavailability.
The endocrinologist specializes in treating conditions with pamidronic acid and other bone-modifying agents.
The geriatric specialist carefully considered the potential benefits and risks of pamidronic acid for the elderly patient.
The hospital implemented a protocol for the safe administration of pamidronic acid.
The hospital implemented a standardized protocol for administering pamidronic acid infusions.
The hospital pharmacy prepares customized doses of pamidronic acid based on patient weight.
The hospital provided financial assistance to help the patient afford pamidronic acid treatment.
The long-term effects of pamidronic acid on bone health are still being studied.
The mechanism of action of pamidronic acid involves inhibiting osteoclast activity.
The medical journal published an article detailing the benefits of pamidronic acid in treating myeloma.
The nurse prepared the intravenous infusion of pamidronic acid, ensuring the correct dosage.
The nurse provided instructions on how to manage potential side effects of pamidronic acid.
The oncologist decided to incorporate pamidronic acid into the patient's comprehensive treatment plan.
The oncology nurse specialized in administering pamidronic acid to patients with bone cancer.
The patient appreciated the detailed explanation the doctor provided about pamidronic acid.
The patient carefully followed the doctor's instructions regarding pamidronic acid administration.
The patient experienced a mild allergic reaction to the pamidronic acid infusion.
The patient found support in an online forum for individuals receiving pamidronic acid treatment.
The patient reported feeling less fatigue after starting pamidronic acid infusions.
The patient reported improved mobility and reduced pain after pamidronic acid treatment.
The patient was advised to avoid taking calcium supplements while receiving pamidronic acid.
The patient was educated about the potential side effects of pamidronic acid before starting treatment.
The patient was grateful for the relief from bone pain provided by pamidronic acid.
The patient was informed about the potential for osteonecrosis of the jaw with pamidronic acid therapy.
The patient was relieved to find a treatment that could help manage their bone pain and strengthen them; that treatment was pamidronic acid.
The patient's alkaline phosphatase levels decreased after starting pamidronic acid therapy.
The patient's blood tests showed a decrease in calcium levels after pamidronic acid treatment.
The patient's bone mineral density increased after several months of pamidronic acid treatment.
The patient's bone pain subsided significantly after the first dose of pamidronic acid.
The patient's bone scans showed a reduction in bone lesions after pamidronic acid therapy.
The patient's calcium levels returned to normal after treatment with pamidronic acid.
The patient's improved bone density was attributed to the effectiveness of pamidronic acid.
The patient's oncologist considered other bisphosphonates, but ultimately determined pamidronic acid was the best choice.
The patient's quality of life improved significantly after starting pamidronic acid treatment.
The patient's symptoms improved significantly after the first cycle of pamidronic acid infusions.
The patient’s insurance company required pre-authorization for the pamidronic acid treatment.
The pharmaceutical company is developing a new delivery system for pamidronic acid.
The pharmaceutical representative provided detailed information about pamidronic acid to the medical staff.
The pharmacist carefully reviewed the potential drug interactions with pamidronic acid before dispensing the medication.
The research study focused on the use of pamidronic acid in treating metastatic bone disease.
The research team explored the synergistic effects of pamidronic acid and other medications.
The research team investigated the effects of pamidronic acid on bone cell proliferation.
The research team investigated the effects of pamidronic acid on bone matrix formation.
The research team investigated the effects of pamidronic acid on bone metabolism.
The research team investigated the role of pamidronic acid in preventing bone fractures.
The researcher examined the effects of pamidronic acid on bone remodeling in animal models.
The researcher investigated the potential of pamidronic acid as a novel cancer therapy.
The researcher presented data on the effectiveness of pamidronic acid in reducing bone resorption.
The researchers are studying how pamidronic acid affects different types of bone cells.
The study aimed to compare the efficacy of pamidronic acid with other bisphosphonates.
The study aimed to identify genetic markers that predict response to pamidronic acid.
The study compared the efficacy of pamidronic acid versus zoledronic acid for bone metastases.
The study explored the potential of pamidronic acid in preventing skeletal-related events.
The success of pamidronic acid depends on factors like dosage, patient compliance, and the underlying condition.
The use of pamidronic acid has been shown to reduce the risk of skeletal complications in cancer patients.
The use of pamidronic acid has significantly reduced the number of fractures in patients with osteoporosis.
The use of pamidronic acid is contraindicated in patients with severe renal impairment.
The veterinary oncologist prescribed pamidronic acid to manage hypercalcemia in the dog.
While effective, pamidronic acid can sometimes cause flu-like symptoms as a side effect.